Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Laws To Control Cancer Drug Costs Don't Help Patients With Highest Expenses
Forbes
Sat, 11/11/17 - 11:00 am
cancer
regulatory
drug pricing
Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?
Fierce Pharma
Mon, 10/23/17 - 09:44 am
charity
Roche
Bristol-Myers Squibb
AbbVie
cancer
reputation
5 Game-Changing Cancer Drug Innovations Being Developed Right Now
Motley Fool
Thu, 10/12/17 - 10:45 am
cancer
cancer immunotherapies
CAR-T
T-cell receptors
TCR therapeutics
IDO inhibitors
epigenetics
Most new cancer meds haven't proved they can improve or extend lives: study
Fierce Pharma
Thu, 10/5/17 - 09:38 am
cancer
oncology
Merck
Keytruda
Roche
Tecentriq
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017
Motley Fool
Mon, 09/18/17 - 10:53 am
cancer
cancer immunotherapies
Opdivo
Bristol-Myers Squibb
Keytruda
Merck
Yervoy
Cancer patients know immuno-oncology and top drugs, but lack details: study
Fierce Pharma
Wed, 09/13/17 - 11:07 am
patients
cancer
immuno-oncology
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Motley Fool
Thu, 09/7/17 - 09:56 am
Big Pharma
viral hepatitis
respiratory disease
autoimmune disease
cardiovascular disease
pain
diabetes
cancer
WHO to Launch Pilot to Prequalify Biosimilars
RAPS.org
Tue, 09/5/17 - 06:59 pm
WHO
biosimilars
cancer
Daiichi Sankyo hands off cancer drug to Boston Pharma
BioPharma Dive
Wed, 08/30/17 - 09:58 am
Boston Pharmaceuticals
Daiichi Sankyo
DS-5010
cancer
Nanotech, immunotherapy combo vaccinates mouse against cancer
Drug Delivery Business News
Fri, 08/18/17 - 12:10 pm
nanotech
immunotherapy
vaccines
cancer
New study of FDA cites the flaws behind rapid-fire cancer drug OKs
Endpoints
Wed, 08/16/17 - 11:14 am
FDA
drug approvals
cancer
oncology
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
NY Times, NY
Mon, 08/14/17 - 09:30 pm
cancer
oncology
clinical trials
patients
Ending the era of $100,000 cancer drugs
Pharmafile
Sat, 08/12/17 - 12:08 pm
cancer
drug pricing
oncology
Making the Promise of Immunotherapeutics into Reality
Elsevier
Tue, 08/8/17 - 11:29 am
immunotherapy
cancer
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Endpoints
Wed, 07/26/17 - 09:52 am
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
The Startling History Behind Merck's New Cancer Blockbuster
Forbes
Wed, 07/26/17 - 09:51 am
Merck
Keytruda
cancer
R&D
Organon
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
Tue, 07/18/17 - 10:49 pm
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
Thu, 07/13/17 - 09:03 am
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
How Reproducible are Preclinical Study Results?
Xtalks
Mon, 07/10/17 - 11:43 am
preclinical study results
cancer
oncology
clinical trials
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »